Parkside Financial Bank & Trust Spectrum Pharmaceuticals Inc Transaction History

Parkside Financial Bank & Trust

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $191 - $365	-151 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$2.15 - $3.82 $842 - $1,497	-392 Reduced 72.19%	151 $0
Q2 2021 Aug 06, 2021	BUY	$2.89 - $4.45 $797 - $1,228	276 Added 103.37%	543 $2,000
Q4 2020 Feb 09, 2021	BUY	$3.38 - $5.14 $118 - $179	35 Added 15.09%	267 $1,000
Q3 2020 Nov 06, 2020	BUY	$2.99 - $4.9 $239 - $392	80 Added 52.63%	232 $1,000
Q1 2020 May 05, 2020	BUY	$1.83 - $3.45 $29 - $55	16 Added 11.76%	152 $0
Q3 2019 Nov 05, 2019	BUY	$7.03 - $9.7 $956 - $1,319	136 New	136 $1,000
Q2 2019 Aug 06, 2019	SELL	$7.36 - $11.26 $853 - $1,306	-116 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$9.08 - $11.84 $254 - $331	28 Added 31.82%	116 $1,000
Q4 2018 Jan 31, 2019	BUY	$6.39 - $16.99 $153 - $407	24 Added 37.5%	88 $1,000
Q1 2018 May 02, 2018	SELL	$16.09 - $23.07 $209 - $299	-13 Reduced 16.88%	64 $1,000
Q3 2017 Oct 27, 2017	BUY	$8.75 - $14.07 $673 - $1,083	77	77 $1,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.